Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors
about
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-MycChemical probes targeting epigenetic proteins: Applications beyond oncology.Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas.Unfolding the pathogenesis of scleroderma through genomics and epigenomics.Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent.Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.Cellular analysis of the action of epigenetic drugs and probes.Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine GliomaA Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma.Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode.Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4Epigenetic regulation in medulloblastoma.Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple).Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles.Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors
P2860
Q28559676-18405505-71F3-441F-A514-D1059A2CA4E5Q33751386-E208C912-611A-4265-B7D3-E74340248EDDQ33842529-0F47B387-AE15-4949-99FA-67CDF3E811F0Q34552042-7000BC3F-CA1C-4723-B90E-30A89BEA8976Q38681645-7D1DDDC8-EF19-4A83-9BC5-913979CBD442Q38682574-06544F62-043B-42FF-8E60-6E2D57CAD03CQ38695896-F8169BA1-D9EF-46A3-914D-C7ED1EB7FA36Q39069889-3B7C3247-FE9A-4F05-8ECE-E501BD0B3603Q39077976-B5580B77-5A2F-4E9A-81CA-C02C01918ACDQ39154575-58BAFC72-61EA-43EF-B278-1FD889238B90Q39207675-F5829093-F095-4311-82A8-A48FDCFCF5F4Q41109977-057D2E6A-1C2E-404F-84DD-A32DC42A36A7Q41514200-D9189A1E-9FBA-4787-A8A4-92331DF8AF07Q42293431-5058E67D-332C-4E73-93F2-7CC08BAEA36AQ47900778-83266196-F9EF-4934-962A-58DCC8069AAEQ48265414-B7E65CF4-9479-491B-B2BB-F643CD1D7676Q52659146-4357A98A-1CB3-48C0-9FAC-368AE0898ABCQ54957650-7424D4EF-35A6-4FCB-A2C4-73E353EAF1F5Q56892267-D9763129-D606-4011-8CEF-AC8EBC70B4BD
P2860
Bromodomain Inhibitor Review: Bromodomain and Extra-terminal Family Protein Inhibitors as a Potential New Therapy in Central Nervous System Tumors
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@ast
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@en
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@nl
type
label
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@ast
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@en
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@nl
prefLabel
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@ast
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@en
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@nl
P2860
P3181
P356
P1433
P1476
Bromodomain Inhibitor Review: ...... Central Nervous System Tumors
@en
P2093
Elizabeth Wadhwa
P2860
P3181
P356
10.7759/CUREUS.620
P407
P577
2016-01-01T00:00:00Z